| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
2e-07 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
| mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-06 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0007 |